Expanding the Phenotypic Spectrum of SPG7 Rare Damaging Variants: Insights From a Hungarian Cohort
Clinical Genetics · 2025-08 · 108 (2) · 124-133
DOI: 10.1111/cge.14719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 20.02.2025. Verfasst von Idris Janos Jimoh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Metalloendopeptidases, Spastic Paraplegia, Hereditary, Paraplegia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TKP2021-EGA-25, TKP2021-NVA-15, and OTKA 139010 from the National Research, Development and Innovation Office, and the Eötvös Loránd Research Network, Multiomi….
Abstract (Originalsprache)
Mitochondria‐associated paraplegin dysfunction is primarily linked to spastic paraplegia; however, genetic alterations in SPG7 have been associated with a broader spectrum of clinical symptoms. To identify disease‐causing variants in the SPG7 gene, 437 patients with spastic ataxia, mitochondrial dysfunction‐associated symptoms, or motoneuron lesions detected by EMG have been tested. We aimed to assess the clinical spectrum and determine the frequency of damaging variants within patient groups, particularly those less studied. Using ACMG criteria, we identified 10 pathogenic or likely pathogenic variants, 5 variants of uncertain significance with predicted damaging effects, and a probable risk factor variant in 58 patients. We identified 25 biallelic and 33 monoallelic cases. The most common variant was p. Leu78Ter ( N = 23), followed by p. Ala510Val ( N = 21). The point prevalence of SPG7‐associated conditions in Hungary in 2024 is 0.46 per 100 000. In addition to well‐characterized cohorts, SPG7 alterations were frequently identified in cohorts with multisystemic mitochondrial disease and lower motoneuron lesions. Multiple mtDNA deletions and histological abnormalities were consistently observed across all groups. In monoallelic cases, no evidence of a digenic effect involving AFG3L2 was found. Both autosomal dominant and recessive inheritance patterns were documented, with monoallelic cases typically presenting with a milder phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary.
- Doctoral School of Interdisciplinary Medicine, University of Szeged, Szeged, Hungary.
- HUN-REN Multiomics Neurodegeneration Research Group, Hungarian Research Network, Budapest, Hungary.
- Department of Neurology, University of Debrecen, Debrecen, Hungary.
- Department of Neurology, University of Szeged, Szeged, Hungary.
- HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, Danube Neuroscience Research Laboratory, University of Szeged, Szeged, Hungary.
Förderung
- TKP2021-EGA-25, TKP2021-NVA-15, and OTKA 139010 from the National Research, Development and Innovation Office, and the Eötvös Loránd Research Network, Multiomi…
Zitieren
APA
Jimoh, I. J., Balicza, P., Szlepak, T., Csaban, D., Gal, A., Geresi, A., Grosz, Z., Palasti, A., Boczan, J., Klivenyi, P., & Molnar, M. J. (2025). Expanding the Phenotypic Spectrum of SPG7 Rare Damaging Variants: Insights From a Hungarian Cohort. Clinical Genetics, 108(2), 124-133. https://doi.org/10.1111/cge.14719
Vancouver
Jimoh IJ, Balicza P, Szlepak T, Csaban D, Gal A, Geresi A, et al. Expanding the Phenotypic Spectrum of SPG7 Rare Damaging Variants: Insights From a Hungarian Cohort. Clinical Genetics. 2025;108(2):124-133. doi:10.1111/cge.14719
BibTeX
@article{Jimoh2025,
author = {Jimoh, Idris Janos and Balicza, Peter and Szlepak, Tamas and Csaban, Dora and Gal, Aniko and Geresi, Adrienn and Grosz, Zoltan and Palasti, Agnes and Boczan, Judit and Klivenyi, Peter and Molnar, Maria Judit},
title = {Expanding the Phenotypic Spectrum of SPG7 Rare Damaging Variants: Insights From a Hungarian Cohort},
journal = {Clinical Genetics},
year = {2025},
volume = {108},
number = {2},
pages = {124--133},
doi = {10.1111/cge.14719}
}
EUVIMED